Anna Lembke, MD, is an associate professor in the department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She is medical director of Stanford Addiction Medicine, program director for the Stanford Addiction Medicine Fellowship, and chief of the Stanford Addiction Medicine Dual Diagnosis Clinic. Dr. Lembke received her BA in Humanities from Yale University and her MD from Stanford University, where she also completed her residency in Psychiatry and fellowship in mood disorders. She is a diplomate of the American Board of Psychiatry and Neurology, and of the American Board of Addiction Medicine. Dr. Lembke has developed multiple teaching programs on drug misuse and addiction therapy. She has held multiple leadership and mentorship positions and received the Stanford’s Chairman’s Award for Clinical Innovation, and the Stanford Departmental Award for Outstanding Teaching. She chaired the Planning Committee for the California Society of Addiction Medicine (CSAM) Annual Addiction Medicine Conference and is the president of the Addiction Medicine Fellowship Directors Association (AMFDA). She has published over 50 peer-reviewed articles, chapters, and commentaries, is author of the bestselling book, Drug Dealer, MD: How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop (Johns Hopkins University Press, November 2016).